Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
Parenterally administered ascorbic acid modulates sepsis-induced inflammation and coagulation in experimental animal models. The objective of this randomized, double-blind, placebo-controlled, phase I trial was to determine the safety of intravenously ...
No comments:
Post a Comment